Actonel (risedronate) for osteoporosis
The FDA has now approved Actonel (risedronate) for osteoporosis. The HPB is considering this new indication for Canada.
Actonel is a bisphosphonate...similar to Fosamax (alendronate). But until now, Actonel was approved only for Paget's disease.
The new U.S. indication is to prevent or treat osteoporosis in postmenopausal women...or in patients taking glucocorticoids.